Aventis Pharma Q3 net up 15.85 pc to Rs 54.8 cr

NEW DELHI: Aventis Pharma today reported a 15.85 per cent increase in its net profit to Rs 54.8 crore for the third quarter ended September 30, 2011 boosted by overall good sales.

The company had posted a net profit of Rs 47.3 crore for the quarter ended September 30, 2010 Aventis Pharma said in a filing to BSE.

Net sales of the company stood at Rs 312.7 crore for the quarter ended September 30,2011 as against Rs 275.6 crore for the corresponding period previous fiscal.

During the quarter the company entered into a definitive agreement with Universal Medicare Private Ltd to acquire marketing and distribution business of branded neutraceutical formulations in India, Aventis Pharma said.

Scrips of Aventis Pharma today closed at Rs 2,350 per share, up 0.05 pc.